Mapping epitopes of U1-70K autoantibodies at single-amino acid resolution

References

• Arbuckle, M. R., M. T. McClain, M. V. Rubertone, et al. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349: 1526–1533
   PubMed Web of Science ®Google Scholar
• Ehrenstein, M. R., D. R. Katz, M. H. Griffiths, et al. 1995. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int. 48: 705–711
   PubMed Web of Science ®Google Scholar
• ter Borg, E. J., G. Horst, E. J. Hummel, et al. 1990. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 33: 634–643
   PubMed Web of Science ®Google Scholar
• Kattah, N. H., M. G. Kattah, and P. J. Utz. 2010. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol. Rev. 233: 126–145
   PubMed Web of Science ®Google Scholar
• Habets, W. J., D. J. de Rooij, M. H. Hoet, et al. 1985. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin. Exp. Immunol. 59: 457–466
   PubMed Web of Science ®Google Scholar
• Reichlin, M., and W. J. Van Venrooij. 1991. Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin. Exp. Immunol. 83: 286–290
   PubMed Web of Science ®Google Scholar
• Habets, W. J., D. J. de Rooij, M. H. Salden, et al. 1983. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin. Exp. Immunol. 54: 265–276
   PubMed Web of Science ®Google Scholar
• St Clair, E. W., C. C. Query, R. Bentley, et al. 1990. Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 54: 266–280
   PubMedGoogle Scholar
• Sharp, G. C., W. S. Irvin, E. M. Tan, et al. 1972. Mixed connective tissue disease – an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52: 148–159
   PubMed Web of Science ®Google Scholar
• Sharp, G. C., W. S. Irvin, C. M. May, et al. 1976. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N. Engl. J. Med. 295: 1149–1154
   PubMed Web of Science ®Google Scholar
• Guldner, H. H., H. J. Netter, C. Szostecki, et al. 1988. Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera. J. Immunol. 141: 469–475
   PubMed Web of Science ®Google Scholar
• Netter, H. J., H. H. Guldner, C. Szostecki, and H. Will. 1990. Major autoantigenic sites of the (U1) small nuclear ribonucleoprotein-specific 68-kDa protein. Scand. J. Immunol. 32: 163–176
   PubMed Web of Science ®Google Scholar
• Cram, D. S., N. Fisicaro, R. L. Coppel, et al. 1990. Mapping of multiple B cell epitopes on the 70-kilodalton autoantigen of the U1 ribonucleoprotein complex. J. Immunol. 145: 630–635
   PubMed Web of Science ®Google Scholar
• Degen, W. G., M. Pieffers, E. Welin-Henriksson, et al. 2000. Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein. Eur. J. Immunol. 30: 3029–3038
   PubMed Web of Science ®Google Scholar
• Nyman, U., I. Lundberg, E. Hedfors, and I. Pettersson. 1990. Recombinant 70-kD protein used for determination of autoantigenic epitopes recognized by anti-RNP sera. Clin. Exp. Immunol. 81: 52–58
   PubMed Web of Science ®Google Scholar
• Takeda, Y., U. Nyman, A. Winkler, et al. 1991. Antigenic domains on the U1 small nuclear ribonucleoprotein-associated 70K polypeptide: a comparison of regions selectively recognized by human and mouse autoantibodies and by monoclonal antibodies. Clin. Immunol. Immunopathol. 61: 55–68
   PubMedGoogle Scholar
• James, J. A., R. H. Scofield, and J. B. Harley. 1994. Basic amino acids predominate in the sequential autoantigenic determinants of the small nuclear 70K ribonucleoprotein. Scand. J. Immunol. 39: 557–566
   PubMed Web of Science ®Google Scholar
• Monneaux, F., J. P. Briand, and S. Muller. 2000. B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4(+) T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein. Eur. J. Immunol. 30: 2191–2200
   PubMed Web of Science ®Google Scholar
• Poole, B. D., R. I. Schneider, J. M. Guthridge, et al. 2009. Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. Arthritis Rheum. 60: 848–859
   PubMed Web of Science ®Google Scholar
• Henriksson, E. W., and I. Pettersson. 1997. Autoepitope-mapping of the U1-70K protein with human-Drosophila chimeric proteins. J. Autoimmun. 10: 559–568
   PubMed Web of Science ®Google Scholar
• Welin Henriksson, E., M. Wahren-Herlenius, I. Lundberg, et al. 1999. Key residues revealed in a major conformational epitope of the U1-70K protein. Proc. Natl. Acad. Sci. USA 96: 14487–14492
   PubMed Web of Science ®Google Scholar
• Greidinger, E. L., and R. W. Hoffman. 2001. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B′/B proteins as predominant U1 RNP immunogens. Arthritis Rheum. 44: 368–375
   PubMed Web of Science ®Google Scholar
• Price, J. V., S. Tangsombatvisit, G. Xu, et al. 2012. On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein–protein interactions. Nat. Med. 18: 1434–1440
   PubMed Web of Science ®Google Scholar
• Baechler, E. C., F. M. Batliwalla, G. Karypis, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610–2615
   PubMed Web of Science ®Google Scholar
• Kattah, N. H., E. W. Newell, J. A. Jarrell, et al. 2015. Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease. Proc. Natl. Acad. Sci. USA 112: 3044–3049
   PubMed Web of Science ®Google Scholar
• Zimmer, R., H. R. Scherbarth, O. L. Rillo, et al. 2013. Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial. Ann. Rheum. Dis. 72: 1830–1835
   PubMed Web of Science ®Google Scholar
• Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
   PubMed Web of Science ®Google Scholar
• Price, J. V., J. A. Jarrell, D. Furman, et al. 2013. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS One 8: e64555
   PubMed Web of Science ®Google Scholar
• R Core Team. 2013. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing
   Google Scholar
• Kolde, R. 2013. Pretty Heatmaps. 0.7.7 ed. R package
   Google Scholar
• Guldner, H. H., H. J. Netter, C. Szostecki, et al. 1990. Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus. J. Exp. Med. 171: 819–829
   PubMed Web of Science ®Google Scholar
• Graham, K. L., W. H. Robinson, L. Steinman, and P. J. Utz. 2004. High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases. Autoimmunity 37: 269–272
   PubMed Web of Science ®Google Scholar
• Query, C. C., and J. D. Keene. 1987. A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 51: 211–220
   PubMed Web of Science ®Google Scholar
• Monneaux, F., and S. Muller. 2001. Key sequences involved in the spreading of the systemic autoimmune response to spliceosomal proteins. Scand. J. Immunol. 54: 45–54
   PubMed Web of Science ®Google Scholar
• James, J. A., and J. B. Harley. 1996. Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns. J. Immunol. 156: 4018–4026
   PubMed Web of Science ®Google Scholar
• Utz, P. J., and P. Anderson. 1998. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 41: 1152–1160
   PubMed Web of Science ®Google Scholar
• Doyle, H. A., M. L. Yang, M. T. Raycroft, et al. 2014. Autoantigens: novel forms and presentation to the immune system. Autoimmunity 47: 220–233
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen, L. A., D. K. Miller, G. J. Anhalt, and A. Rosen. 1994. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269: 30757–30760
   PubMed Web of Science ®Google Scholar
• Degen, W. G., Y. Aarssen, G. J. Pruijn, et al. 2000. The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule. Cell Death Differ. 7: 70–79
   PubMed Web of Science ®Google Scholar
• Burdt, M. A., R. W. Hoffman, S. L. Deutscher, et al. 1999. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 42: 899–909
   PubMed Web of Science ®Google Scholar
• Margaux, J., G. Hayem, E. Palazzo, et al. 1998. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus. Rev. Rhum. Engl. Ed. 65: 378–386
   PubMedGoogle Scholar
• Murakami, A., K. Kojima, K. Ohya, et al. 2002. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease. Arthritis Rheum. 46: 3273–3282
   PubMed Web of Science ®Google Scholar
• Stewart, M. L., E. Fire, A. E. Keating, and L. D. Walensky. 2010. The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer. Nat. Chem. Biol. 6: 595–601
   PubMed Web of Science ®Google Scholar
• Dorow, D. S., P. T. Shi, F. R. Carbone, et al. 1985. Two large immunogenic and antigenic myoglobin peptides and the effects of cyclisation. Mol. Immunol. 22: 1255–1264
   PubMed Web of Science ®Google Scholar
• Osterfeld, S. J., H. Yu, R. S. Gaster, et al. 2008. Multiplex protein assays based on real-time magnetic nanotag sensing. Proc. Natl. Acad. Sci. USA 105: 20637–20640
   PubMed Web of Science ®Google Scholar